K
Kim A. Eagle
Researcher at University of Michigan
Publications - 852
Citations - 85694
Kim A. Eagle is an academic researcher from University of Michigan. The author has contributed to research in topics: Aortic dissection & Myocardial infarction. The author has an hindex of 129, co-authored 823 publications receiving 75160 citations. Previous affiliations of Kim A. Eagle include University of Wisconsin Hospital and Clinics & Spaulding Rehabilitation Hospital.
Papers
More filters
Journal ArticleDOI
Revascularization in the acute coronary syndromes
Troy M. LaBounty,Kim A. Eagle +1 more
TL;DR: Coronary heart disease is the leading cause of death worldwide, and occurs when the coronary arteries are unable to supply adequate oxygenated blood to the myocardium, which in turn can lead to ischemia and infarction of myocardial tissue.
Journal ArticleDOI
Debakey types i and ii are distinct subsets within type a dissection: a report from the international registry of acute aortic dissection
Nilla Majahalme,Louis P. Kohl,Artur Evangelista Masip,Mark J. Russo,Stuart Hutchison,Eduardo Bossone,Toru Suzuki,Reed E. Pyeritz,Peter J. Oberwalder,Lori D. Conklin,Daniel G. Montgomery,Eric M. Isselbacher,Christoph A. Nienaber,Kim A. Eagle,Kevin M. Harris +14 more
TL;DR: The DeBakey classification divides Type A acute aortic dissection (AAD) into Type I and Type II; the latter limited to the ascending aorta.
Journal ArticleDOI
OPTIMIZE-ing treatment for patients with heart failure.
Todd M. Koelling,Kim A. Eagle +1 more
TL;DR: Design OPTIMIZE-HF is a large hospital-based scheme comprising an internet registry of patients with HF, and participating hospitals were provided with a process of care intervention (PrCI) ‘toolkit’ that included discharge checklists and best-practice algorithms.
Journal ArticleDOI
There and back again: the story of perioperative β-blockade.
Daniel Alyeshmerni,Kim A. Eagle +1 more
TL;DR: A population-based approach was used to effectively characterize the evolution of perioperative β-blocker usage in the context of an evolving dogma, evidence base, and guideline recommendations, and this investigation is highly important because approximately 200 million patients undergo noncardiac surgery each year.